Iranian general populations' and health care providers' preferences for benefits and harms of statin therapy for primary prevention of cardiovascular disease

被引：0

作者：

Hassan Saadati

Hamid Reza Baradaran

Goodarz Danaei

Afshin Ostovar

Farzad Hadaegh

Leila Janani

Ewout W. Steyerberg

Davood Khalili

机构：

[1] Iran University of Medical Sciences,Department of Epidemiology, School of Public Health

[2] Medical Sciences and Nutrition University of Aberdeen,Ageing Clinical and Experimental Research Team, Institute of Applied Health Sciences, School of Medicine

[3] Iran University of Medical Sciences,Endocrine Research Center, Institute of Endocrinology and Metabolism

[4] Harvard TH Chan School of Public Health,Department of Global Health and Population and Department of Epidemiology

[5] Tehran University of Medical Sciences,Osteoporosis Research Center, Endocrinology and Metabolism Clinical Sciences Institute

[6] Research Institute for Endocrine Sciences,Prevention of Metabolic Disorders Research Center

[7] Shahid Beheshti University of Medical Sciences,Department of Biostatistics, School of Public Health

[8] Iran University of Medical Sciences,Department of Biomedical Data Sciences

[9] Leiden University Medical Center,Department of Public Health

[10] Erasmus MC,Department of Biostatistics and Epidemiology

[11] Research Institute for Endocrine Sciences,undefined

[12] Shahid Beheshti University of Medical Sciences,undefined

来源：

BMC Medical Informatics and Decision Making | / 20卷

关键词：

Preferences; Statins; Benefit harm outcomes; Primary prevention; Cardiovascular disease;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

共 50 条

[1] Iranian general populations' and health care providers' preferences for benefits and harms of statin therapy for primary prevention of cardiovascular disease
Saadati, Hassan
Baradaran, Hamid Reza
Danaei, Goodarz
Ostovar, Afshin
Hadaegh, Farzad
Janani, Leila
Steyerberg, Ewout W.
Khalili, Davood
BMC MEDICAL INFORMATICS AND DECISION MAKING, 2020, 20 (01)
[2] Older adult preferences regarding benefits and harms of statin and aspirin therapy for cardiovascular primary prevention
Wang, Frances M.
Yebyo, Henock G.
Ballew, Shoshana H.
Cainzos-Achirica, Miguel
Boyd, Cynthia
Puhan, Milo A.
Matsushita, Kunihiro
Blaha, Michael J.
Schoenborn, Nancy L.
AMERICAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2023, 13
[3] Statin Therapy for Primary Prevention of Cardiovascular Disease
Taylor, Fiona C.
Huffman, Mark
Ebrahim, Shah
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2013, 310 (22): : 2451 - 2452
[4] Statin therapy for the primary prevention of cardiovascular disease: Pros
Razavi, Alexander C.
Mehta, Anurag
Sperling, Laurence S.
ATHEROSCLEROSIS, 2022, 356 : 41 - 45
[5] Statin therapy in primary and secondary cardiovascular disease prevention
Paparodis, Rodis D.
Bantouna, Dimitra
Livadas, Sarantis
Angelopoulos, Nicholas
CURRENT ATHEROSCLEROSIS REPORTS, 2024, 27 (01)
[6] Statin therapy for the primary prevention of cardiovascular disease: Cons
Durai, Vivek
Redberg, Rita F.
ATHEROSCLEROSIS, 2022, 356 : 46 - 49
[7] Harms and Benefits of Using Aspirin for Primary Prevention of Cardiovascular Disease: A Narrative Overview
Lippi, Giuseppe
Danese, Elisa
Favaloro, Emmanuel J.
SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2019, 45 (02): : 157 - 163
[8] BALANCING HARMS AND BENEFITS OF STATINS FOR PRIMARY PREVENTION OF CARDIOVASCULAR DISEASE: A MICROSIMULATION MODELLING STUDY
Chen, Tao
Moeez, Subhani
Soiland-Reyes, Claudia
Simon, Capewell
Martin, O'Flaherty
Chris, Kypridemos
JOURNAL OF EPIDEMIOLOGY AND COMMUNITY HEALTH, 2022, 76 : A20 - A20
[9] Combination niacin and statin therapy in primary and secondary prevention of cardiovascular disease
Levy, DR
Pearson, TA
CLINICAL CARDIOLOGY, 2005, 28 (07) : 317 - 320
[10] Role of Statin Therapy in Primary Prevention of Cardiovascular Disease in Elderly Patients
Timo E. Strandberg
Current Atherosclerosis Reports, 2019, 21

← 1 2 3 4 5 →